XML 55 R41.htm IDEA: XBRL DOCUMENT v3.25.1
Equity (Tables)
12 Months Ended
Mar. 31, 2025
Equity [Abstract]  
Common Stock Reserved for Issuance
The Company has shares of common stock reserved for issuance as follows (in thousands):
March 31, 2025
Common stock warrants280 
2010 Plan
Options outstanding10,445 
2021 Plan
Awards outstanding
3,828 
Shares available for future grant40,449 
2021 ESPP9,742 
Options outstanding outside the Plans2,568 
Total67,312 
Stock Option Activity
Stock option activities within the Plans as well as outside of the Plans were as follows:
Number of Shares
(in thousands)
Weighted-Average
Exercise Price
Average Remaining Contractual Term
(in years)
Aggregate Intrinsic Value (in thousands)
Balance, March 31, 202417,480 $4.60 5.72$389,931 
Options exercised(4,339)3.86 
Options forfeited or expired(128)7.38 
Balance, March 31, 202513,013 4.82 4.92692,422 
Vested and exercisable as of March 31, 202510,057 3.96 4.64543,794 
Vested and expected to vest as of March 31, 202513,013 4.82 4.92692,422 
Restricted Stock Unit Activity
The following table summarizes RSU activity (in thousands, except per share information):
Number of SharesWeighted-
Average
Grant Date Fair Value
Unvested balance, March 31, 20242,093 $33.79 
Granted3,049 29.60 
Vested(1,554)31.20 
Forfeited(241)27.08 
Unvested balance, March 31, 20253,347 31.66 
Stock-Based Compensation Expense
Total stock-based compensation expense recognized in the consolidated statement of operations was as follows (in thousands):
Fiscal Year Ended March 31,
202520242023
Cost of revenue$11,001 $9,479 $9,634 
Research and development19,394 11,978 12,583 
Sales and marketing26,323 16,857 16,939 
General and administrative15,668 9,116 8,678 
Restructuring
— 3,646 — 
Total stock-based compensation expense$72,386 $51,076 $47,834